Smart Port CT H787CT80STPDNF0Recalls & reported problems
Angiodynamics, Inc. · Smart Port CT Single Titanium Port System with Attachable 8.0F x 66cm Polyurethane Catheter and 8 F Introducer Kit (with Non-Filled Suture Holes) · Class 2 · Implant
All models of Smart Port CT (36)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 15051684018043), received between Sep 15, 2025 and Sep 24, 2026 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Fracture” (1 report).
2 other recalls cover devices cleared under the same FDA submission (K062414); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Fracture1
Patient problems
- Bacteremia1
- Bacterial Infection1
- Chest Pain1
- Chills1
- Fever1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjurySep 24, 2026Adverse Event Without Identified Device or Use Problem
On or about (b)(6) 2024, Plaintiff underwent placement of an Angio Dynamics Smart Port port catheter product, with model number H787CT80STPDNF0.The Smart Port device was implanted by Dr. (b)(6), at (b)(6) in (b)(6), for the principal purpose of medication administration for Plaintiff's Crohn's disease.On or about (b)(6) 2024, Plaintiff presented to Dr. (b)(6) at (b)(6) who diagnosed the Plaintiff with bacteremia.On or about (b)(6) 2024, Plaintiff presented to (b)(6) at (b)(6) to have the Smart Port removed due to the Plaintiff's infection.
Patient problems: Bacteremia
MAUDE report 50876706 ↗MalfunctionDec 13, 2025Fracture; Fracture
ON OR ABOUT (B)(6) 2022, PLAINTIFF UNDERWENT PLACEMENT OF THE ANGIODYNAMICS SMARTPORT CATHETER PRODUCT, WITH MODEL NUMBER H787CT80STPDNF0, AND LOT NUMBER 5727278. THE SMARTPORT WAS IMPLANTED BY DR. (B)(6) AT (B)(6) FOR THE PURPOSE OF ONGOING MYASTHENIA GRAVIS. ON OR ABOUT (B)(6) 2024, PLAINTIFF PRESENTED TO (B)(6) WITH COMPLAINTS OF CHEST PAIN. SUBSEQUENTLY, PLAINTIFF UNDERWENT AN MRI WHICH REVEALED A FRACTURED SMARTPORT CATHETER. ON OR ABOUT (B)(6) 2024, PLAINTIFF UNDERWENT REMOVAL OF THE SMARTPORT RESERVOIR AND CATHETER FRAGMENTS AT (B)(6). THE PROCEDURE WAS PERFORMED BY DR. (B)(6).
Patient problems: Chest Pain
MAUDE report 23797711 ↗InjurySep 15, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON OR ABOUT (B)(6) 2016, PLAINTIFF UNDERWENT PLACEMENT OF AN ANGIODYNAMICS SMARTPORT PORT CATHETER PRODUCT, WITH MODEL NUMBER CT80STPD-NF, AND LOT NUMBER 4987769. THIS SMARTPORT DEVICE WAS COMPRISED OF A PORT BODY AND POLYURETHANE CATHETER. THE DEVICE WAS IMPLANTED BY DR.(B)(6), M.D, (B)(6), FOR ADMINISTRATION OF CHEMOTHERAPY. ON OR ABOUT (B)(6) 2016, PLAINTIFF PRESENTED TO (B)(6), WITH COMPLAINTS OF FEVERS AND CHILLS. BLOOD CULTURES WERE DRAWN FROM PLAINTIFF'S SMARTPORT, WHICH CAME BACK POSITIVE FOR SERRATIA MARCESCENS. PLAINTIFF WAS TREATED WITH MEDICATION. ON OR ABOUT (B)(6) 2016, PLAINTIFF PRESENTED TO (B)(6), WITH COMPLAINTS OF A FEVER. BLOOD CULTURES WERE DRAWN AND CAME BACK POSITIVE FOR SERRATIA MARCESCENS. PLAINTIFF'S MEDICAL TEAM DETERMINED THAT THE SMARTPORT WOULD NEED TO BE REMOVED. ON OR ABOUT (B)(6) 2016, PLAINTIFF UNDERWENT REMOVAL OF THE DEFECTIVE SMARTPORT, AND THE REMOVAL PROCEDURE WAS PERFORMED BY DR. (B)(6), M.D (B)(6).
Patient problems: Bacterial Infection; Chills; Fever
MAUDE report 23053789 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K062414. One submission often covers many models, so check the product and lot details in each record.
- Z-1466-2021 · Feb 22, 2021 · TerminatedSmart Port CT-Implantable Port Catalogue #: CT96STSD-VI, CT96STSA-VI - Product Usage: indicated for any patient requiring repeated access of the vascular system, for delivery of me
- Z-0056-2012 · Aug 1, 2011 · Terminated8F Smart Port CT, Catalog number: CT80STPD and CT80STPD-NF; AngioDynamics, INC. The Smart Port CT Implantable Port is a Single Titanium Port System with Attachable 8.0 Fr. Polyur
Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices
- PowerPort M.R.I., Groshong 9808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR3 deaths834 reports
- PowerPort ClearVUE 1608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR18 deaths571 reports
- PowerPort ClearVUE 5608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR31 deaths542 reports
- PowerPort M.R.I., ChronoFlex 1808000Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR19 deaths513 reports
- PowerPort M.R.I., ChronoFlex 1808060Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR1 recall15 deaths383 reports
- PowerPort M.R.I., Groshong 1808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR10 deaths304 reports
- PowerPort M.R.I., ChronoFlex 1829500Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR6 deaths197 reports
- BardPort M.R.I. 0602680Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR2 deaths179 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page